RedHill Biopharma Ltd. (RDHL) Earnings History
Annual and quarterly earnings data from 2011 to 2024
Loading earnings history...
RDHL EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
RDHL Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 60.3% | -181.7% | -102.8% |
| 2023 | 47.0% | 193.4% | 366.2% |
| 2022 | 46.1% | -69.3% | -116.0% |
| 2021 | 42.4% | -94.6% | -114.0% |
| 2020 | 42.7% | -99.0% | -118.4% |
Download Data
Export RDHL earnings history in CSV or JSON format
Free sign-in required to download data
RedHill Biopharma Ltd. (RDHL) Earnings Overview
As of May 8, 2026, RedHill Biopharma Ltd. (RDHL) reported trailing twelve-month net income of -$9M, reflecting -115.2% year-over-year growth. The company earned $-5.17 per diluted share over the past four quarters, with a net profit margin of -102.8%.
Looking at the long-term picture, RDHL's historical earnings data spans multiple years. The company achieved its highest annual net income of $24M in fiscal 2023.
RedHill Biopharma Ltd. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CMPX (-$68M net income), PRAX (-$327M net income), IRWD ($151M net income, 8.1% margin), RDHL has comparable earnings metrics. Compare RDHL vs CMPX →
RDHL Earnings vs Peers
Earnings metrics vs comparable public companies
RDHL Historical Earnings Data (2011–2024)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$8M | -134.6% | -$15M | $-7.00 | -102.8% | -181.7% |
| 2023 | $24M | +133.4% | $13M | $46.00 | 366.2% | 193.4% |
| 2022 | -$72M | +26.7% | -$43M | $-600.00 | -116.0% | -69.3% |
| 2021 | -$98M | -28.3% | -$81M | $-1000.00 | -114.0% | -94.6% |
| 2020 | -$76M | -80.1% | -$64M | $-1000.00 | -118.4% | -99.0% |
| 2019 | -$42M | -9.0% | -$43M | $-700.00 | -672.5% | -686.7% |
| 2018 | -$39M | +14.8% | -$39M | $-850.00 | -464.4% | -470.5% |
| 2017 | -$46M | -55.1% | -$52M | $-1300.00 | -1136.6% | -1297.0% |
| 2016 | -$29M | -39.3% | -$31M | $-1100.00 | -29079.2% | -30240.6% |
| 2015 | -$21M | -96.9% | -$22M | $-950.00 | -703000.0% | -733400.0% |
See RDHL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RDHL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RDHL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRDHL — Frequently Asked Questions
Quick answers to the most common questions about buying RDHL stock.
Is RDHL growing earnings?
RDHL EPS fell to $-5.17, with earnings declining -115.2%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-9M.
What are RDHL's profit margins?
RedHill Biopharma Ltd. net margin is -102.8%, with operating margin at -181.7%. Below-average margins reflect competitive or cost pressures.
How consistent are RDHL's earnings?
RDHL earnings data spans 2011-2024. The declining earnings trend is -115.2% YoY. Historical data enables comparison across business cycles.